Risk stratification for distant recurrence of resected early stage non–small cell lung cancer is under construction

Abstract

The risk of distant recurrence in completely resected early stage non-small cell lung cancer remains poorly defined, and this shortcoming limits the adoption of adjuvant therapy strategies.